Improved disease activity with fosdagrocorat (PF‐04171327), a partial agonist of the glucocorticoid receptor, in patients with rheumatoid arthritis: a Phase 2 randomized study

AIM: To assess efficacy and safety of fosdagrocorat (PF‐04171327), a potential dissociated agonist of the glucocorticoid receptor, in rheumatoid arthritis (RA) patients. METHODS: This multicenter, double‐blind, parallel‐group, active‐ and placebo‐controlled Phase 2 study (NCT00938587) randomized 86...

Descripción completa

Detalles Bibliográficos
Autores principales: Stock, Thomas, Fleishaker, Dona, Wang, Xin, Mukherjee, Arnab, Mebus, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084298/
https://www.ncbi.nlm.nih.gov/pubmed/28328159
http://dx.doi.org/10.1111/1756-185X.13053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084298/
https://www.ncbi.nlm.nih.gov/pubmed/28328159
http://dx.doi.org/10.1111/1756-185X.13053

Ejemplares similares